{"id":64008,"date":"2024-08-08T05:25:23","date_gmt":"2024-08-08T05:25:23","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&p=64008"},"modified":"2026-05-16T05:24:27","modified_gmt":"2026-05-16T05:24:27","slug":"hucog-10000iu-injection","status":"publish","type":"product","link":"https:\/\/medsbase.com\/ro\/product\/hucog-10000iu-injection\/","title":{"rendered":"HUCOG 10000IU Injection"},"content":{"rendered":"
\n

R\u0103spuns rapid<\/h3>\n

HUCOG 10000IU Injection<\/strong> \u2014 HUCOG 10000 IU Injection is a human chorionic gonadotropin (hCG) preparation used in fertility treatment for women (ovulation trigger and luteal support) and in selected hypogonadism \/ cryptorchidism protocols in men. Hospital or specialist administration recommended.<\/p>\n<\/div>\n

Substitution Notice:<\/strong> All HUCOG 10000IU Injection orders are currently being fulfilled with ZyHCG HP 10000IU Injection<\/a> (same active ingredient, same strength, same manufacturer group) until cold-chain shipping for HUCOG is established.<\/div>\n
\nCe beneficii ofer\u0103 MedsBase:<\/strong> Produc\u0103tor certificat WHO-GMP \u00b7 Ambalaj discret \u00b7 Livrare la nivel mondial \u00b7 Peste 1.400 de recenzii verificate ale clien\u021bilor<\/a>\n<\/div>\n

\ud83d\udce6 Fiecare comand\u0103 este acoperit\u0103 de politica noastr\u0103 de Politica noastr\u0103 de Reexpediere Garantat\u0103<\/strong><\/a> \u2014 dac\u0103 coletul dumneavoastr\u0103 nu sose\u0219te \u00een 20 de zile lucr\u0103toare, \u00eel relivr\u0103m.<\/p>\n

De ce s\u0103 comanzi de la MedsBase<\/h3>\n

Medicamentele noastre generice sunt procurate de la produc\u0103tori certifica\u021bi WHO-GMP \u0219i expediate la nivel mondial \u00een ambalaje discrete \u0219i simple \u2014 f\u0103r\u0103 denumirea medicamentului pe exteriorul coletului. Pl\u0103\u021bile cu cardul sunt procesate printr-un procesor reglementat (descrierile de pe extrasul de cont includ un procesor de pl\u0103\u021bi cu card reglementat \u2014 niciodat\u0103 \u201cMedsBase\u201d sau numele vreunui medicament). Accept\u0103m \u0219i criptomonede \u0219i transferuri bancare SEPA. Fiecare comand\u0103 este sus\u021binut\u0103 de Politica noastr\u0103 de Asigurare pentru Relivrare.<\/p>\n

What Is HUCOG 10000IU?<\/h2>\n

HUCOG 10000IU is a highly purified Human Chorionic Gonadotropin (HCG) injection manufactured by Bharat Serums & Vaccines Ltd.<\/strong>, one of India’s largest and most established biopharmaceutical companies with over six decades of experience in serum-based biologics. Each vial contains 10,000 International Units of urinary-derived HCG in lyophilized (freeze-dried) powder form, supplied with a sterile solvent ampoule for reconstitution.<\/p>\n

HCG is a glycoprotein hormone naturally produced during pregnancy. Its molecular structure closely resembles luteinizing hormone (LH), which allows it to bind to LH receptors and stimulate the same downstream effects \u2014 ovulation in women and testosterone production in men. This dual mechanism makes HUCOG 10000IU one of the most versatile injectable hormones used in reproductive medicine and endocrinology.<\/p>\n

Bharat Serums manufactures HUCOG under strict WHO-GMP conditions. The urinary extraction process uses multiple chromatographic purification steps to isolate HCG while removing impurities, resulting in a product with high bioactivity and low immunogenicity.<\/p>\n

Uses of HUCOG 10000IU<\/h2>\n

HUCOG 10000IU is prescribed across a range of clinical indications in both women and men. For a comprehensive overview, see our guide on HCG injection uses, dosage, and side effects<\/a>.<\/p>\n

Female Fertility: Ovulation Trigger<\/h3>\n

The most common use of HUCOG 10000IU is as a “trigger shot” in assisted reproduction. After controlled ovarian stimulation with FSH-based medications (such as Gonal-F or Menopur), a single injection of 5,000 to 10,000 IU of HCG is administered to induce final follicular maturation and ovulation. This is standard protocol in both IUI<\/strong> (intrauterine insemination) and IVF<\/strong> (in vitro fertilization) cycles. Ovulation typically occurs 36 to 40 hours after the trigger injection, allowing precise timing of insemination or egg retrieval.<\/p>\n

HCG is also used for luteal phase support<\/strong> after embryo transfer, where repeated lower doses help maintain progesterone levels during the critical implantation window.<\/p>\n

Male Hypogonadism<\/h3>\n

In men with hypogonadotropic hypogonadism \u2014 where the pituitary gland fails to produce adequate LH \u2014 HCG acts as a direct LH substitute. It stimulates Leydig cells in the testes to produce testosterone endogenously, often restoring both testosterone levels and spermatogenesis without the fertility-suppressing effects of exogenous testosterone.<\/p>\n

TRT Adjunct (Testosterone Replacement Therapy)<\/h3>\n

Men on testosterone replacement therapy commonly experience testicular atrophy and suppressed sperm production because exogenous testosterone shuts down the hypothalamic-pituitary-gonadal axis. Co-administering low-dose HCG (typically 250 to 500 IU two to three times per week) maintains intratesticular testosterone production, preserves testicular volume, and supports ongoing fertility \u2014 a significant concern for younger men on TRT.<\/p>\n

Criptorhidie<\/h3>\n

In prepubertal boys with undescended testes, HCG therapy can stimulate testicular descent by promoting testosterone production within the testes. This non-surgical approach is typically attempted before orchiopexy and is most effective when the testes are palpable in the inguinal canal.<\/p>\n

Post-Cycle Therapy (PCT)<\/h3>\n

After a cycle of anabolic steroids, endogenous testosterone production is suppressed. HCG is used during the early phase of post-cycle therapy to rapidly restore testicular function and testosterone output before transitioning to selective estrogen receptor modulators (SERMs) such as clomiphene or tamoxifen for full hypothalamic-pituitary recovery.<\/p>\n

Dosage by Indication<\/h2>\n

The following table summarizes standard HUCOG dosing protocols. All doses should be individualized under medical supervision.<\/p>\n\n\n\n\n\n\n\n\n\n\n
Indica\u021bie<\/th>\nDoza<\/th>\nFrecven\u021b\u0103<\/th>\nDurat\u0103<\/th>\n<\/tr>\n<\/thead>\n
Female ovulation trigger<\/td>\n5,000 – 10,000 IU<\/td>\nSingle injection<\/td>\nOne-time (per cycle)<\/td>\n<\/tr>\n
Suport pentru faza luteal\u0103<\/td>\n5.000 UI<\/td>\nEvery 3 – 4 days<\/td>\nUp to 3 injections<\/td>\n<\/tr>\n
Hipogonadismul masculin<\/td>\n1,000 – 2,000 IU<\/td>\n2 – 3x per week<\/td>\n3 – 6 months<\/td>\n<\/tr>\n
TRT adjunct<\/td>\n250 – 500 IU<\/td>\n2 – 3x per week<\/td>\nOngoing (with TRT)<\/td>\n<\/tr>\n
Criptorhidie<\/td>\n500 – 1,000 IU<\/td>\n2 – 3x per week<\/td>\n4 – 6 weeks<\/td>\n<\/tr>\n
Terapie post-ciclu (PCT)<\/td>\n1,000 – 2,000 IU<\/td>\nLa dou\u0103 zile<\/td>\n2 – 3 weeks<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

How to Administer HUCOG 10000IU<\/h2>\n

HUCOG 10000IU is supplied as a lyophilized powder in a glass vial with a separate ampoule of bacteriostatic water or sterile sodium chloride solution. For detailed step-by-step mixing instructions, see our guide on how to mix HCG (Human Gonadotropin)<\/a>.<\/p>\n

Reconstitution<\/h3>\n
    \n
  1. Wash hands thoroughly and clean the vial stopper and ampoule neck with an alcohol swab.<\/li>\n
  2. Snap open the solvent ampoule and draw the entire contents into a syringe.<\/li>\n
  3. Inject the solvent slowly into the HUCOG powder vial, directing the stream against the glass wall (not directly onto the powder) to avoid excessive foaming.<\/li>\n
  4. Swirl gently until the powder dissolves completely. Do not shake. The resulting solution should be clear and colorless.<\/li>\n<\/ol>\n

    Injection Route<\/h3>\n

    HUCOG 10000IU may be administered by injec\u021bie intramuscular\u0103 (IM)<\/strong> sau subcutanat (SC)<\/strong> injection. IM injection is the traditional route, typically into the upper outer quadrant of the gluteal muscle or the lateral thigh (vastus lateralis). SC injection into abdominal fat is increasingly common, particularly for lower-dose protocols such as TRT adjunct dosing, and studies show comparable bioavailability between the two routes.<\/p>\n

    Storage After Reconstitution<\/h3>\n